In this report, the global Radiopharmaceuticals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Radiopharmaceuticals for these regions, from 2012 to 2022 (forecast), covering United States China Europe Japan Southeast Asia India Global Radiopharmaceuticals market competition by top manufacturers/players, with Radiopharmaceuticals sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including Bracco Imaging Bayer Mallinckrodt Nordion Triad Isotopes Lantheus IBA Group GE Healthcare China Isotope & Radiation Jubilant Pharma Eli Lilly Advanced Accelerator Applications SIEMENS Dongcheng Navidea On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Diagnostic Radioisotopes Therapeutic Radioisotopes On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including Oncology Cardiology Other If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents Global Radiopharmaceuticals Sales Market Report 2017 1 Radiopharmaceuticals Market Overview 1.1 Product Overview and Scope of Radiopharmaceuticals 1.2 Classification of Radiopharmaceuticals by Product Category 1.2.1 Global Radiopharmaceuticals Market Size (Sales) Comparison by Type (2012-2022) 1.2.2 Global Radiopharmaceuticals Market Size (Sales) Market Share by Type (Product Category) in 2016 1.2.3 Diagnostic Radioisotopes 1.2.4 Therapeutic Radioisotopes 1.3 Global Radiopharmaceuticals Market by Application/End Users 1.3.1 Global Radiopharmaceuticals Sales (Volume) and Market Share Comparison by Application (2012-2022) 1.3.2 Oncology 1.3.3 Cardiology 1.3.4 Other 1.4 Global Radiopharmaceuticals Market by Region 1.4.1 Global Radiopharmaceuticals Market Size (Value) Comparison by Region (2012-2022) 1.4.2 United States Radiopharmaceuticals Status and Prospect (2012-2022) 1.4.3 China Radiopharmaceuticals Status and Prospect (2012-2022) 1.4.4 Europe Radiopharmaceuticals Status and Prospect (2012-2022) 1.4.5 Japan Radiopharmaceuticals Status and Prospect (2012-2022) 1.4.6 Southeast Asia Radiopharmaceuticals Status and Prospect (2012-2022) 1.4.7 India Radiopharmaceuticals Status and Prospect (2012-2022) 1.5 Global Market Size (Value and Volume) of Radiopharmaceuticals (2012-2022) 1.5.1 Global Radiopharmaceuticals Sales and Growth Rate (2012-2022) 1.5.2 Global Radiopharmaceuticals Revenue and Growth Rate (2012-2022) 2 Global Radiopharmaceuticals Competition by Players/Suppliers, Type and Application 2.1 Global Radiopharmaceuticals Market Competition by Players/Suppliers 2.1.1 Global Radiopharmaceuticals Sales and Market Share of Key Players/Suppliers (2012-2017) 2.1.2 Global Radiopharmaceuticals Revenue and Share by Players/Suppliers (2012-2017) 2.2 Global Radiopharmaceuticals (Volume and Value) by Type 2.2.1 Global Radiopharmaceuticals Sales and Market Share by Type (2012-2017) 2.2.2 Global Radiopharmaceuticals Revenue and Market Share by Type (2012-2017) 2.3 Global Radiopharmaceuticals (Volume and Value) by Region 2.3.1 Global Radiopharmaceuticals Sales and Market Share by Region (2012-2017) 2.3.2 Global Radiopharmaceuticals Revenue and Market Share by Region (2012-2017) 2.4 Global Radiopharmaceuticals (Volume) by Application 3 United States Radiopharmaceuticals (Volume, Value and Sales Price) 3.1 United States Radiopharmaceuticals Sales and Value (2012-2017) 3.1.1 United States Radiopharmaceuticals Sales and Growth Rate (2012-2017) 3.1.2 United States Radiopharmaceuticals Revenue and Growth Rate (2012-2017) 3.1.3 United States Radiopharmaceuticals Sales Price Trend (2012-2017) 3.2 United States Radiopharmaceuticals Sales Volume and Market Share by Players 3.3 United States Radiopharmaceuticals Sales Volume and Market Share by Type 3.4 United States Radiopharmaceuticals Sales Volume and Market Share by Application 4 China Radiopharmaceuticals (Volume, Value and Sales Price) 4.1 China Radiopharmaceuticals Sales and Value (2012-2017) 4.1.1 China Radiopharmaceuticals Sales and Growth Rate (2012-2017) 4.1.2 China Radiopharmaceuticals Revenue and Growth Rate (2012-2017) 4.1.3 China Radiopharmaceuticals Sales Price Trend (2012-2017) 4.2 China Radiopharmaceuticals Sales Volume and Market Share by Players 4.3 China Radiopharmaceuticals Sales Volume and Market Share by Type 4.4 China Radiopharmaceuticals Sales Volume and Market Share by Application 5 Europe Radiopharmaceuticals (Volume, Value and Sales Price) 5.1 Europe Radiopharmaceuticals Sales and Value (2012-2017) 5.1.1 Europe Radiopharmaceuticals Sales and Growth Rate (2012-2017) 5.1.2 Europe Radiopharmaceuticals Revenue and Growth Rate (2012-2017) 5.1.3 Europe Radiopharmaceuticals Sales Price Trend (2012-2017) 5.2 Europe Radiopharmaceuticals Sales Volume and Market Share by Players 5.3 Europe Radiopharmaceuticals Sales Volume and Market Share by Type 5.4 Europe Radiopharmaceuticals Sales Volume and Market Share by Application 6 Japan Radiopharmaceuticals (Volume, Value and Sales Price) 6.1 Japan Radiopharmaceuticals Sales and Value (2012-2017) 6.1.1 Japan Radiopharmaceuticals Sales and Growth Rate (2012-2017) 6.1.2 Japan Radiopharmaceuticals Revenue and Growth Rate (2012-2017) 6.1.3 Japan Radiopharmaceuticals Sales Price Trend (2012-2017) 6.2 Japan Radiopharmaceuticals Sales Volume and Market Share by Players 6.3 Japan Radiopharmaceuticals Sales Volume and Market Share by Type 6.4 Japan Radiopharmaceuticals Sales Volume and Market Share by Application 7 Southeast Asia Radiopharmaceuticals (Volume, Value and Sales Price) 7.1 Southeast Asia Radiopharmaceuticals Sales and Value (2012-2017) 7.1.1 Southeast Asia Radiopharmaceuticals Sales and Growth Rate (2012-2017) 7.1.2 Southeast Asia Radiopharmaceuticals Revenue and Growth Rate (2012-2017) 7.1.3 Southeast Asia Radiopharmaceuticals Sales Price Trend (2012-2017) 7.2 Southeast Asia Radiopharmaceuticals Sales Volume and Market Share by Players 7.3 Southeast Asia Radiopharmaceuticals Sales Volume and Market Share by Type 7.4 Southeast Asia Radiopharmaceuticals Sales Volume and Market Share by Application 8 India Radiopharmaceuticals (Volume, Value and Sales Price) 8.1 India Radiopharmaceuticals Sales and Value (2012-2017) 8.1.1 India Radiopharmaceuticals Sales and Growth Rate (2012-2017) 8.1.2 India Radiopharmaceuticals Revenue and Growth Rate (2012-2017) 8.1.3 India Radiopharmaceuticals Sales Price Trend (2012-2017) 8.2 India Radiopharmaceuticals Sales Volume and Market Share by Players 8.3 India Radiopharmaceuticals Sales Volume and Market Share by Type 8.4 India Radiopharmaceuticals Sales Volume and Market Share by Application 9 Global Radiopharmaceuticals Players/Suppliers Profiles and Sales Data 9.1 Bracco Imaging 9.1.1 Company Basic Information, Manufacturing Base and Competitors 9.1.2 Radiopharmaceuticals Product Category, Application and Specification 9.1.2.1 Product A 9.1.2.2 Product B 9.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017) 9.1.4 Main Business/Business Overview 9.2 Bayer 9.2.1 Company Basic Information, Manufacturing Base and Competitors 9.2.2 Radiopharmaceuticals Product Category, Application and Specification 9.2.2.1 Product A 9.2.2.2 Product B 9.2.3 Bayer Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017) 9.2.4 Main Business/Business Overview 9.3 Mallinckrodt 9.3.1 Company Basic Information, Manufacturing Base and Competitors 9.3.2 Radiopharmaceuticals Product Category, Application and Specification 9.3.2.1 Product A 9.3.2.2 Product B 9.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017) 9.3.4 Main Business/Business Overview 9.4 Nordion 9.4.1 Company Basic Information, Manufacturing Base and Competitors 9.4.2 Radiopharmaceuticals Product Category, Application and Specification 9.4.2.1 Product A 9.4.2.2 Product B 9.4.3 Nordion Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017) 9.4.4 Main Business/Business Overview 9.5 Triad Isotopes 9.5.1 Company Basic Information, Manufacturing Base and Competitors 9.5.2 Radiopharmaceuticals Product Category, Application and Specification 9.5.2.1 Product A 9.5.2.2 Product B 9.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017) 9.5.4 Main Business/Business Overview 9.6 Lantheus 9.6.1 Company Basic Information, Manufacturing Base and Competitors 9.6.2 Radiopharmaceuticals Product Category, Application and Specification 9.6.2.1 Product A 9.6.2.2 Product B 9.6.3 Lantheus Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017) 9.6.4 Main Business/Business Overview 9.7 IBA Group 9.7.1 Company Basic Information, Manufacturing Base and Competitors 9.7.2 Radiopharmaceuticals Product Category, Application and Specification 9.7.2.1 Product A 9.7.2.2 Product B 9.7.3 IBA Group Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017) 9.7.4 Main Business/Business Overview 9.8 GE Healthcare 9.8.1 Company Basic Information, Manufacturing Base and Competitors 9.8.2 Radiopharmaceuticals Product Category, Application and Specification 9.8.2.1 Product A 9.8.2.2 Product B 9.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017) 9.8.4 Main Business/Business Overview 9.9 China Isotope & Radiation 9.9.1 Company Basic Information, Manufacturing Base and Competitors 9.9.2 Radiopharmaceuticals Product Category, Application and Specification 9.9.2.1 Product A 9.9.2.2 Product B 9.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017) 9.9.4 Main Business/Business Overview 9.10 Jubilant Pharma 9.10.1 Company Basic Information, Manufacturing Base and Competitors 9.10.2 Radiopharmaceuticals Product Category, Application and Specification 9.10.2.1 Product A 9.10.2.2 Product B 9.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2012-2017) 9.10.4 Main Business/Business Overview 9.11 Eli Lilly 9.12 Advanced Accelerator Applications 9.13 SIEMENS 9.14 Dongcheng 9.15 Navidea 10 Radiopharmaceuticals Maufacturing Cost Analysis 10.1 Radiopharmaceuticals Key Raw Materials Analysis 10.1.1 Key Raw Materials 10.1.2 Price Trend of Key Raw Materials 10.1.3 Key Suppliers of Raw Materials 10.1.4 Market Concentration Rate of Raw Materials 10.2 Proportion of Manufacturing Cost Structure 10.2.1 Raw Materials 10.2.2 Labor Cost 10.2.3 Manufacturing Process Analysis of Radiopharmaceuticals 10.3 Manufacturing Process Analysis of Radiopharmaceuticals 11 Industrial Chain, Sourcing Strategy and Downstream Buyers 11.1 Radiopharmaceuticals Industrial Chain Analysis 11.2 Upstream Raw Materials Sourcing 11.3 Raw Materials Sources of Radiopharmaceuticals Major Manufacturers in 2016 11.4 Downstream Buyers 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Marketing Channel 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 Market Effect Factors Analysis 13.1 Technology Progress/Risk 13.1.1 Substitutes Threat 13.1.2 Technology Progress in Related Industry 13.2 Consumer Needs/Customer Preference Change 13.3 Economic/Political Environmental Change 14 Global Radiopharmaceuticals Market Forecast (2017-2022) 14.1 Global Radiopharmaceuticals Sales Volume, Revenue and Price Forecast (2017-2022) 14.1.1 Global Radiopharmaceuticals Sales Volume and Growth Rate Forecast (2017-2022) 14.1.2 Global Radiopharmaceuticals Revenue and Growth Rate Forecast (2017-2022) 14.1.3 Global Radiopharmaceuticals Price and Trend Forecast (2017-2022) 14.2 Global Radiopharmaceuticals Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022) 14.2.1 Global Radiopharmaceuticals Sales Volume and Growth Rate Forecast by Regions (2017-2022) 14.2.2 Global Radiopharmaceuticals Revenue and Growth Rate Forecast by Regions (2017-2022) 14.2.3 United States Radiopharmaceuticals Sales Volume, Revenue and Growth Rate Forecast (2017-2022) 14.2.4 China Radiopharmaceuticals Sales Volume, Revenue and Growth Rate Forecast (2017-2022) 14.2.5 Europe Radiopharmaceuticals Sales Volume, Revenue and Growth Rate Forecast (2017-2022) 14.2.6 Japan Radiopharmaceuticals Sales Volume, Revenue and Growth Rate Forecast (2017-2022) 14.2.7 Southeast Asia Radiopharmaceuticals Sales Volume, Revenue and Growth Rate Forecast (2017-2022) 14.2.8 India Radiopharmaceuticals Sales Volume, Revenue and Growth Rate Forecast (2017-2022) 14.3 Global Radiopharmaceuticals Sales Volume, Revenue and Price Forecast by Type (2017-2022) 14.3.1 Global Radiopharmaceuticals Sales Forecast by Type (2017-2022) 14.3.2 Global Radiopharmaceuticals Revenue Forecast by Type (2017-2022) 14.3.3 Global Radiopharmaceuticals Price Forecast by Type (2017-2022) 14.4 Global Radiopharmaceuticals Sales Volume Forecast by Application (2017-2022) 15 Research Findings and Conclusion 16 Appendix 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Disclaimer